The efficacy and safety of tirzepatide, with a special focus on cardiovascular safety, were investigated in the 52-week SURPASS-4 trial testing tirzepatide versus insulin glargine in adults with T2D and a high cardiovascular risk under inadequate glycemic control at baseline on one to three oral glucose-lowering medications (metformin, sulfonylurea, SGLT-2 inhibitor) (54, 74)
When evaluating cognitive supplements, consider: Human clinical studies Transparent labeling Third-party testing Proper dosing Potential medication interactions Long-term safety data Stimulant content Quality manufacturing standards Lifestyle factors remain foundational for cognitive performance, including: Sleep quality Physical activity Nutrition Stress management Blood sugar balance Social connection Cognitive stimulation Brain supplements should support (not replace) healthy lifestyle habits
Ophthalmic Genet
Sermorelin often pairs with GHRPs or other secretagogues in sophisticated protocols designed by experienced researchers
GLP-1 also activates Akt/PKB and prevents apoptosis of INS-1 cells in response to glucolipotoxicity or staurosporin 20,21
However, there have been growing concerns about its safety, with reports of severe side effects leading to numerous lawsuits
